Cargando…

A QSAR model of benzoxazole derivatives as potential inhibitors for inosine 5`-monophosphate dehydrogenase from Cryptosporidium parvum

Cryptosporidium parvum is the common enteric protozoan pathogen causing cryptosporidiosis in human. Available drugs to treat cryptosporidiosis are ineffective and there is yet no vaccine against C. parvum. Therefore, it is of interest to design an improved yet effective drug against C. parvum. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Teotia, Pratibha, Prakash Dwivedi, Surya, Dwivedi, Neeraja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267954/
https://www.ncbi.nlm.nih.gov/pubmed/28149045
http://dx.doi.org/10.6026/97320630012119
_version_ 1782500726189064192
author Teotia, Pratibha
Prakash Dwivedi, Surya
Dwivedi, Neeraja
author_facet Teotia, Pratibha
Prakash Dwivedi, Surya
Dwivedi, Neeraja
author_sort Teotia, Pratibha
collection PubMed
description Cryptosporidium parvum is the common enteric protozoan pathogen causing cryptosporidiosis in human. Available drugs to treat cryptosporidiosis are ineffective and there is yet no vaccine against C. parvum. Therefore, it is of interest to design an improved yet effective drug against C. parvum. Here, we docked benzoxazole derivatives (collected from literature) with inosine 5`- monophosphate dehydrogenase (IMPDH) from Cryptosporidium parvum using the program AutoDock 4.2. The docked protein - inhibitor complex structure was optimized using molecular dynamics simulation for 5 ps with the CHARMM-22 force field using NAMD (NAnoscale Molecular Dynamics program) incorporated in visual molecular dynamics (VMD 1.9.2) and then evaluating the stability of complex structure by calculating RMSD values. NAMD is a parallel, object-oriented molecular dynamics code designed for high-performance simulation of large biomolecular systems. A quantitative structure activity relationship (QSAR) model was built using energy-based descriptors as independent variable and pIC50 value as dependent variable of fifteen known benzoxazole derivatives with C. parvum IMPDH protein, yielding correlation coefficient r2 of 0.7948. The predictive performance of QSAR model was assessed using different cross-validation procedures. Our results suggest that a ligand-receptor binding interaction for inosine 5`-monophosphate dehydrogenase using a QSAR model is promising approach to design more potent inosine 5`-monophosphate dehydrogenase inhibitors prior to their synthesis.
format Online
Article
Text
id pubmed-5267954
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Biomedical Informatics
record_format MEDLINE/PubMed
spelling pubmed-52679542017-02-01 A QSAR model of benzoxazole derivatives as potential inhibitors for inosine 5`-monophosphate dehydrogenase from Cryptosporidium parvum Teotia, Pratibha Prakash Dwivedi, Surya Dwivedi, Neeraja Bioinformation Hypothesis Cryptosporidium parvum is the common enteric protozoan pathogen causing cryptosporidiosis in human. Available drugs to treat cryptosporidiosis are ineffective and there is yet no vaccine against C. parvum. Therefore, it is of interest to design an improved yet effective drug against C. parvum. Here, we docked benzoxazole derivatives (collected from literature) with inosine 5`- monophosphate dehydrogenase (IMPDH) from Cryptosporidium parvum using the program AutoDock 4.2. The docked protein - inhibitor complex structure was optimized using molecular dynamics simulation for 5 ps with the CHARMM-22 force field using NAMD (NAnoscale Molecular Dynamics program) incorporated in visual molecular dynamics (VMD 1.9.2) and then evaluating the stability of complex structure by calculating RMSD values. NAMD is a parallel, object-oriented molecular dynamics code designed for high-performance simulation of large biomolecular systems. A quantitative structure activity relationship (QSAR) model was built using energy-based descriptors as independent variable and pIC50 value as dependent variable of fifteen known benzoxazole derivatives with C. parvum IMPDH protein, yielding correlation coefficient r2 of 0.7948. The predictive performance of QSAR model was assessed using different cross-validation procedures. Our results suggest that a ligand-receptor binding interaction for inosine 5`-monophosphate dehydrogenase using a QSAR model is promising approach to design more potent inosine 5`-monophosphate dehydrogenase inhibitors prior to their synthesis. Biomedical Informatics 2016-06-15 /pmc/articles/PMC5267954/ /pubmed/28149045 http://dx.doi.org/10.6026/97320630012119 Text en © 2016 Biomedical Informatics This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
spellingShingle Hypothesis
Teotia, Pratibha
Prakash Dwivedi, Surya
Dwivedi, Neeraja
A QSAR model of benzoxazole derivatives as potential inhibitors for inosine 5`-monophosphate dehydrogenase from Cryptosporidium parvum
title A QSAR model of benzoxazole derivatives as potential inhibitors for inosine 5`-monophosphate dehydrogenase from Cryptosporidium parvum
title_full A QSAR model of benzoxazole derivatives as potential inhibitors for inosine 5`-monophosphate dehydrogenase from Cryptosporidium parvum
title_fullStr A QSAR model of benzoxazole derivatives as potential inhibitors for inosine 5`-monophosphate dehydrogenase from Cryptosporidium parvum
title_full_unstemmed A QSAR model of benzoxazole derivatives as potential inhibitors for inosine 5`-monophosphate dehydrogenase from Cryptosporidium parvum
title_short A QSAR model of benzoxazole derivatives as potential inhibitors for inosine 5`-monophosphate dehydrogenase from Cryptosporidium parvum
title_sort qsar model of benzoxazole derivatives as potential inhibitors for inosine 5`-monophosphate dehydrogenase from cryptosporidium parvum
topic Hypothesis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267954/
https://www.ncbi.nlm.nih.gov/pubmed/28149045
http://dx.doi.org/10.6026/97320630012119
work_keys_str_mv AT teotiapratibha aqsarmodelofbenzoxazolederivativesaspotentialinhibitorsforinosine5monophosphatedehydrogenasefromcryptosporidiumparvum
AT prakashdwivedisurya aqsarmodelofbenzoxazolederivativesaspotentialinhibitorsforinosine5monophosphatedehydrogenasefromcryptosporidiumparvum
AT dwivedineeraja aqsarmodelofbenzoxazolederivativesaspotentialinhibitorsforinosine5monophosphatedehydrogenasefromcryptosporidiumparvum
AT teotiapratibha qsarmodelofbenzoxazolederivativesaspotentialinhibitorsforinosine5monophosphatedehydrogenasefromcryptosporidiumparvum
AT prakashdwivedisurya qsarmodelofbenzoxazolederivativesaspotentialinhibitorsforinosine5monophosphatedehydrogenasefromcryptosporidiumparvum
AT dwivedineeraja qsarmodelofbenzoxazolederivativesaspotentialinhibitorsforinosine5monophosphatedehydrogenasefromcryptosporidiumparvum